ISOLA TRADING UK LIMITED

Executive Summary

Isola Trading UK Limited shows clear symptoms of financial distress with negative working capital, mounting losses, and reliance on parent company funding. Immediate focus on cash flow improvement, creditor negotiations, and cost control is essential to stabilize and improve financial health. With timely intervention, the company may recover and sustain operations successfully.

ISOLA TRADING UK LIMITED - Analysis Report

Company Number: 14358356

Analysis Date: 2025-07-29 18:36 UTC

Financial Health Assessment Report for ISOLA TRADING UK LIMITED

---

1. Financial Health Score: D

Explanation:
The company is currently exhibiting signs of financial distress. Key indicators such as negative net current assets and shareholders' funds, coupled with substantial losses and increased creditors, point toward an unhealthy financial state. While the company is still a going concern based on directors' assertions and support from its parent company, the balance sheet shows a weakened financial position demanding urgent attention.

---

2. Key Vital Signs

Metric	2024 (£)	2023 (£)	Interpretation
Current Assets	595,805	233,976	Improved liquidity in short-term assets, primarily due to increased debtors.
Cash	99,269	229,466	Significant decrease in cash reserves, a warning sign for liquidity management.
Debtors	496,536	4,510	Sharp increase in amounts owed by customers; potential risk if collection is slow or doubtful.
Current Liabilities	973,672	282,681	Large increase in short-term debts; pressure on immediate cash flow.
Net Current Assets (Working Capital)	-377,867	-48,705	Negative working capital worsening, indicating cash flow strain to meet short-term obligations.
Net Assets (Equity)	-376,913	-47,487	Negative equity reflecting accumulated losses; indicates the company’s liabilities exceed assets.
Retained Earnings (P&L Reserve)	-426,913	-97,487	Accumulated losses deepening, highlighting ongoing unprofitability.
Loss for the Year	-329,426	-97,487	Substantial increase in losses, a critical symptom of operational challenges.
Share Capital	50,000	50,000	Stable equity injection from shareholders; however, insufficient to offset losses.

Additional Notes:

• The company’s going concern status is supported by the parent company deferring repayment of £722,835 owed to it, which is critical to near-term survival.
• Tangible fixed assets are minimal (£954), indicating the company relies largely on current assets and goodwill.
• The auditor’s report is unqualified but draws attention to going concern reliance on the parent company’s financial support.

---

3. Diagnosis: Financial Condition and Symptoms

Symptoms of Distress:

• Negative Working Capital: The company’s current liabilities exceed its current assets by £377,867, implying it may struggle to settle short-term debts on time. This is akin to a patient showing signs of dehydration — the company lacks the immediate liquidity "fluid" to operate smoothly.

• Increasing Losses: A loss of £329,426 compared to £97,487 the previous year signals a worsening operational performance. This loss accumulates in retained earnings, eroding shareholders’ equity and indicating the business is "bleeding" cash.

• Rising Debtors: Debtors ballooned from £4,509 to nearly £496,536. While this suggests sales on credit have increased, it may also reflect poor receivables management or delayed payments, which can choke cash flow — similar to a patient retaining toxins instead of clearing them.

• High Current Liabilities: Current liabilities have tripled, largely due to amounts owed to the parent company. This growing "debt burden" increases financial risk and reduces the company’s flexibility.

• Negative Equity: Shareholders’ funds have turned significantly negative, a red flag indicating the company’s net worth is below zero, akin to a patient’s vital signs falling below safe thresholds.

Underlying Causes:

• The company is in a start-up or growth phase (incorporated in 2022) and appears to be investing heavily in operations or extending credit to customers.
• Reliance on the parent company’s deferred funding is a lifeline but also a risk if this support is withdrawn.
• The business operates in wholesale of waste and scrap and specialized sales agents sectors, which may be capital intensive and sensitive to market fluctuations.

---

4. Prognosis: Future Financial Outlook

If the current trends continue without corrective action, the company risks deeper liquidity crises and potential insolvency. However, the directors’ confidence in going concern, supported by the parent company’s financial backing, provides a window for recovery.

Key factors influencing prognosis:

• Improvement in Cash Flow: Without timely collection of debtors and control over current liabilities, cash flow problems will worsen.
• Reduction in Losses: The company needs to stem losses through cost control, pricing strategies, or operational efficiency.
• Parent Company Support: Continued deferral or conversion of intra-group debts into equity would strengthen financial health.
• Market Conditions: Stability in the waste and scrap wholesale market and sales agents sector will impact revenue generation.

---

5. Recommendations: Steps to Improve Financial Wellness

1. Enhance Cash Flow Management:
   Prioritize collection of outstanding debtors. Implement stricter credit controls and offer incentives for early payment to convert receivables into cash faster. This is akin to rehydrating a patient to restore healthy fluid balance.

2. Negotiate Liabilities:
   Engage with creditors to restructure payment terms, especially the amount owed to the parent company. Consider converting some debt into equity where possible to improve the balance sheet.

3. Cost Control and Efficiency:
   Review operational expenses to reduce the loss-making trend. Identify non-essential costs and streamline processes.

4. Financial Monitoring and Forecasting:
   Implement robust financial forecasting to anticipate cash shortfalls and plan accordingly. Regular financial "check-ups" will help detect symptoms early.

5. Explore Additional Capital Injection:
   If feasible, raise new equity or secure external funding to bolster working capital and reduce reliance on intra-group debt.

6. Strategic Review:
   Assess the business model and market strategy to improve profitability and sustainable growth.

---